Rapid Discovery of a Novel Series of Abl Kinase Inhibitors by Application of an Integrated Microfluidic Synthesis and Screening Platform

Bimbisar Desai(Heptares Therapeutics (United Kingdom)), Adrian G. Wright(Heptares Therapeutics (United Kingdom)), Willem P. van Hoorn(Pfizer (United Kingdom)), Karl R. Gibson(Pfizer (United Kingdom)), Karen Dixon(Heptares Therapeutics (United Kingdom)), Elizabeth Farrant(Heptares Therapeutics (United Kingdom)), Gavin A. Whitlock(Pfizer (United Kingdom)), James E. Mills, Qixing Feng(Heptares Therapeutics (United Kingdom)), David M. Parry(Heptares Therapeutics (United Kingdom)), Trevor Morgan(Heptares Therapeutics (United Kingdom)), Christopher N. Selway(Heptares Therapeutics (United Kingdom)), Manoj K. Ramjee(Napp Pharmaceuticals (United Kingdom)), Gary J. Tarver(University of Dundee)
Journal of Medicinal Chemistry
February 26, 2013
Cited by 143


Related Papers